Weight-loss jabs may have to be used for many years if the long-term benefits to patients and health care systems are to be realised, experts have said.The drugs are sold under brand names like ...

GLP-1 meds may help — or harm — those with bipolar disorder. Read firsthand accounts of mood changes, weight loss, and side ...

Dolores Catania is struggling with weight gain even while taking Mounjaro.

GoodRx says that with the support of a healthcare team, a clear transition plan, and a few cost-saving tools, you can make ...

By triggering weight loss using the likes of Ozempic, people can expect various possible changes to their appearance ...

Omada Health closed 21% higher in its Nasdaq debut after raising $150 million. Backed by strong growth and GLP-1 momentum, ...

Chugai plans to pair its muscle-preserving drug with Eli Lilly's orforglipron, addressing muscle loss in obesity care as the ...

Orforglipron (pronounced or-for-GLIP-ron) might be a mouthful to say, but Indianapolis-based Eli Lilly and Co. sees this ...

In total, the NHS paid £269 million for weight loss and diabetes jabs last year, with most items going to patients who were ...

Experts suggest that weight-loss jabs may require long-term use to achieve lasting benefits for both patients and the NHS.

After a simulation recently showed what happens to your body once you inject the drug, some were left horrified, but now a ...

Type 2 diabetes management knowledge is always evolving. Here, we will examine how some diabetes management myths hold up ...